The company
Fulgent Genetics, Inc.
FLGT · Nasdaq
FLGT stood above a rising 150-day average in 17 of the last 52 weekly readings, including each of the last 2 weeks. It is 6.9% above that average now. Diagnostics & Labs: 48% of its 44 stocks in an uptrend (−2 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 2 in a row
- Industry in uptrend
- 48% -2 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $901K
- Officials’ trades on record
- 0
- Institutions holding
- 139 (-13)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Hanlin GaoChief Scientific Officer | sold | 1,673at $19.66 | 2 Sep 2026filed 3 Sep 2026 |
| Jian XiePresident and COO | sold | 2,127at $19.66 | 2 Sep 2026filed 3 Sep 2026 |
| Hanlin GaoChief Scientific Officer | sold | 939at $19.91 | 27 Aug 2026filed 28 Aug 2026 |
| Jian XiePresident and COO | sold | 1,193at $19.91 | 27 Aug 2026filed 28 Aug 2026 |
| Hanlin GaoChief Scientific Officer | sold | 1,688at $17.89 | 2 Jun 2026filed 3 Jun 2026 |
| Jian XiePresident and COO | sold | 2,146at $17.89 | 2 Jun 2026filed 3 Jun 2026 |
| Hanlin GaoChief Scientific Officer | sold | 945at $17.60 | 27 May 2026filed 28 May 2026 |
| Jian XiePresident and COO | sold | 1,201at $17.60 | 27 May 2026filed 28 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 2,286,669$46.9M | -487,850−17.6% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 789,498$16.2M | -90,652−10.3% |
| JACOBS LEVY EQUITY MANAGEMENT, INCadded · filed 14 Aug 2026 | 782,116$16.0M | +425,757+119.5% |
| JPMORGAN CHASE & COnew · filed 12 Aug 2026 | 756,558$15.5M | +756,558 |
| Diametric Capital, LPadded · filed 14 Aug 2026 | 697,784$14.3M | +336,738+93.3% |
| AMERIPRISE FINANCIAL INCadded · filed 14 Aug 2026 | 670,084$13.8M | +106,709+18.9% |
| DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026 | 625,355$12.8M | -46,309−6.9% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 521,014$10.7M | -63,193−10.8% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 498,673$10.2M | -30,726−5.8% |
| Invenomic Capital Management LPreduced · filed 14 Aug 2026 | 498,287$10.2M | -112,031−18.4% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.